Tomas Kiselak
CIK: 0001830177
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRDN
Viridian Therapeutics, Inc.\DE
Director
Discretionary Trading P&L
Holdings
About Kiselak Tomas
Kiselak Tomas (SEC CIK 0001830177) files insider reports with the SEC as Director of Viridian Therapeutics, Inc.\DE (VRDN).
Signal8 holds 2 ownership filings by Kiselak Tomas, all Form 4s, filed between Jul 2, 2025 and Jul 2, 2026. Those filings report 2 transactions, from Jul 1, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kiselak Tomas's filings is in WALTHAM, MA.
Recent filings by Kiselak Tomas
Other insiders filing for Viridian Therapeutics, Inc.\DE (VRDN)
- Tousignant Jennifer, Chief Legal Officer
- Tripuraneni Radhika, Chief Medical Officer
- CAIN CHRISTOPHER W., Director
- Ajer Jeffrey Robert, Director
- Moses Jennifer K., Director
- Gheuens Sarah, Director